Canada markets closed

Bayer Aktiengesellschaft (BAYN.DE)

XETRA - XETRA Delayed Price. Currency in EUR
Add to watchlist
57.35+0.63 (+1.11%)
At close: 05:37PM CEST
Full screen
Previous Close56.72
Open56.36
Bid0.00 x 28400
Ask0.00 x 2100
Day's Range55.75 - 57.42
52 Week Range43.90 - 67.99
Volume2,173,516
Avg. Volume3,212,519
Market Cap56.342B
Beta (5Y Monthly)1.12
PE Ratio (TTM)25.60
EPS (TTM)2.24
Earnings DateAug 04, 2022
Forward Dividend & Yield2.00 (3.49%)
Ex-Dividend DateMay 02, 2022
1y Target EstN/A
  • News Direct

    A Global Crisis Brings Food Security to the Table

    Every plate of food is the center of a story.

  • Reuters

    UPDATE 2-U.S. Supreme Court again nixes Bayer challenge to weedkiller suits

    The U.S. Supreme Court on Monday rejected another Bayer AG bid to dismiss litigation alleging that its Roundup weedkiller causes cancer as the German pharmaceutical and chemical giant tries to avoid potentially billions of dollars in damages. The justices turned away a Bayer appeal and left in place a lower court decision upholding an $87 million judgment awarded in a lawsuit in California to Alberta and Alva Pilliod, who were diagnosed with cancer after spraying Roundup for more than three decades. The Supreme Court on June 21 rejected a Bayer appeal in a different Roundup case.

  • Reuters

    U.S. Supreme Court again nixes Bayer challenge to weedkiller suits

    (Reuters) -The U.S. Supreme Court on Monday rejected another Bayer AG bid to dismiss litigation alleging that its Roundup weedkiller causes cancer as the German pharmaceutical and chemical giant tries to avoid potentially billions of dollars in damages. The justices turned away a Bayer appeal and left in place a lower court decision upholding an $87 million judgment awarded in a lawsuit in California to Alberta and Alva Pilliod, who were diagnosed with cancer after spraying Roundup for more than three decades. The Supreme Court on June 21 rejected a Bayer appeal in a different Roundup case.